Skip to content

IBM

S&P 500
Favorable · 64/100

IBM

Information Technology
IT Consulting & Other Services

$252.22

1.3%

Updated Today 7:15 PM ET

Price — Past Year

▼ Down 12.0% over the last 12 months

Price 50-day average 200-day averageSource: Yahoo Finance · refreshed daily
Key Metrics

Market Cap

$234.13B

P/E

21.77x

Forward P/E (est.)

15.55x

ROE

35.5%

Revenue Growth

9.7%

EPS Growth

94.5%

Profit Margin

15.6%

FCF Yield

4.5%

Debt / Equity

1.88x

ROIC

Interest Coverage

Current Ratio

0.8x

Dividend Yield

2.5%

Implied Growth (rev. DCF)

3.6%

Rating Score

64/100

Technical Analysis (Educational)
Research

Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what IBM's chart says today, with each tool explained.

Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. IBM trades near $252.22, around its 50-day average ($250.54) and 200-day average ($273.45). Price tangled in its moving averages means there is no clear trend — the stock is ranging.

Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 30 it is oversold — selling has been heavy and a bounce is possible.

MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently negative — short-term momentum is fading.

Volatility — ATR. Average True Range is the typical daily move. IBM's is $14.83 (~5.9% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.

Support & resistance. Over the last month IBM found buyers near $230.94 (support) and sellers near $332.46 (resistance); its 52-week range is $212.34–$332.46. A decisive break beyond either edge often marks the next move.

Volume. The latest session traded 1.3× the 20-day average — about normal. Rising volume on up-days suggests real buying; on down-days, real selling.

Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.

Business Overview
Research

IBM (IBM) is a mega-cap company in the IT Consulting & Other Services industry, part of the Information Technology sector of the S&P 500, with a market value around $234.13B.

In its latest reported year it generated about $67.53B in revenue and $10.59B in net profit.

Our model rates IBM Favorable (64/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.

Revenue Growth
Research

4Y CAGR

4.2%

Revenue moved from $57.35B in 2021 to $67.53B in 2025, a 4.2% compound annual growth rate. The most recent year grew a steady 9.7% year over year. Slower, mature growth is common for established businesses.

Profitability
Research

Gross Margin

58.2%

Operating Margin

15.3%

Net Margin

15.7%

ROE

35.5%

IBM keeps about 15.6% of each sales dollar as net profit, with a 58.2% gross margin and 15.3% operating margin. Return on equity is 35.5%. Margins this wide usually signal pricing power or a cost advantage.

Debt Analysis
Research

Total Debt

$62.94B

Net Debt

$52.13B

Net Debt / EBITDA

Debt / Equity

1.88x

Leverage: debt-to-equity is 1.9x, with a current ratio of 0.8x. That is elevated leverage, which raises risk if earnings or rates move against it. It carries roughly $62.94B of total debt against $10.82B of cash.

Cash Flow Analysis
Research

Operating CF

$13.19B

Free Cash Flow

$12.10B

FCF Margin

17.9%

In the latest year IBM produced about $13.19B of operating cash flow and $12.10B of free cash flow after capital spending. That is a free-cash-flow yield of about 4.5% on today's price. Strong cash generation funds dividends, buybacks, and reinvestment.

Valuation Analysis
Research

P/E

21.77x

P/S

3.77x

P/B

7.8x

EV / EBITDA

IBM trades at 21.8x trailing earnings (about 15.6x on estimated forward earnings), 3.8x sales, and 7.8x book value. Reverse-engineering today's price implies the market expects roughly 3.6% long-term free-cash-flow growth. That is a fairly typical valuation for a profitable company.

Metrics vs. Typical Range

Where this stock sits versus what most companies trade at.

TTM P/E
21.8xFair
Forward P/E
15.6xCheap
P/S ratio
3.8xExpensive
Revenue growth
9.7%Strong
EPS growth
94.5%Strong
Gross margin
58.2%Strong
Net margin
15.6%Strong
ROE
35.5%Strong

Typical ranges are general references (e.g., many stocks trade at ~18–26x earnings), not hard rules. Context only — not investment advice.

Sector Peer Comparison

How IBM stacks up against its Information Technology peers — valuation, profitability, and growth versus the sector median.

In the Information Technology sector (72 S&P 500 companies), IBM ranks #28 of 72 by our overall rating. It trades at a discount versus the sector on earnings (21.8x P/E vs. 35.6x median) with a higher return on equity (35.5% vs. 25.6%) and slower revenue growth (9.7% vs. 17.4%).

P/E vs sector

21.8x

median 35.6x

ROE vs sector

35.5%

median 25.6%

Growth vs sector

9.7%

median 17.4%

Sector rank

#28

of 72 by rating

CompanyP/ERev Gr.Rating
IBMThis stock21.8x9.7%Favorable· 64
ACN10.4x7.3%Favorable· 63
CTSH9.3x6.6%Neutral· 56
IT11.6x2.3%Neutral· 49
PANW19.5%Neutral· 43
WDC37.9x32.0%Strong· 77
QCOM24.3x5.2%Favorable· 60
STX99.7x28.9%Neutral· 57
Information Technology median35.6x17.4%61/100

Valuation vs. quality map

sector medianACNCTSHITWDCQCOMSTXIBMP/E — cheaper ←→ pricierROE — more profitable ↑

The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.

Compare side by side

Peers are the closest Information Technology companies by sub-industry and size. Sector median is across all 72 S&P 500 names in the sector. Educational, not a recommendation.

5-Year Projection Model

Project revenue → earnings → price. Edit the assumptions to build your own case.

2030 price target (Base Case)

$240.70$407.34

vs. $252.22 today · expected CAGR -1%10%

Metric20262027202820292030
Revenue$74.29B$81.72B$89.89B$98.88B$108.77B
Net income$11.89B$13.07B$14.38B$15.82B$17.40B
EPS$12.65$13.91$15.30$16.83$18.52
Share price (low)$164.40$180.84$198.93$218.82$240.70
Share price (high)$278.22$306.04$336.65$370.31$407.34
CAGR (low–high)-35% / 10%-15% / 10%-8% / 10%-3% / 10%-1% / 10%

Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.

Bull Case

The case for IBM:

  • High net margins (15.6%) point to pricing power or efficiency.
  • Strong return on equity (35.5%) shows capital is put to work well.
  • Healthy free-cash-flow yield (~4.5%) funds buybacks and dividends.
  • Pays a 2.5% dividend on top of any price gains.
  • Our model's overall read is Favorable (64/100).
Bear Case

The case against IBM:

  • Elevated leverage (debt/equity 1.9x) adds financial risk.
  • Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Key Risks
Research

Balance-sheet risk — debt/equity of 1.9x magnifies the impact of higher rates or weaker earnings.

Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.

Investment Thesis
Research

On balance, the fundamentals screen favourably: IBM is a mega-cap information technology business growing at a mature pace, with solid profitability, and a heavier debt load to watch. It trades at 21.8x earnings, which our model scores Favorable (64/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.

Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.

Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.